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AbstrACt 
Objectives To investigate the sex-specific association 
between smoking and lung cancer.
Design Systematic review and meta-analysis.
Data sources We searched PubMed and EMBASE from 1 
January 1999 to 15 April 2016 for cohort studies. Cohort 
studies before 1 January 1999 were retrieved from a 
previous meta-analysis. Individual participant data from 
three sources were also available to supplement analyses 
of published literature.
Eligibility criteria for selecting studies Cohort studies 
reporting the sex-specific relative risk (RR) of lung cancer 
associated with smoking.
results Data from 29 studies representing 99 cohort 
studies, 7 million individuals and >50 000 incident lung 
cancer cases were included. The sex-specific RRs and 
their ratio comparing women with men were pooled using 
random-effects meta-analysis with inverse-variance 
weighting. The pooled multiple-adjusted lung cancer RR 
was 6.99 (95% Confidence Interval (CI) 5.09 to 9.59) in 
women and 7.33 (95% CI 4.90 to 10.96) in men. The 
pooled ratio of the RRs was 0.92 (95% CI 0.72 to 1.16; 
I2=89%; p<0.001), with no evidence of publication bias or 
differences across major pre-defined participant and study 
subtypes. The women-to-men ratio of RRs was 0.99 (95% 
CI 0.65 to 1.52), 1.11 (95% CI 0.75 to 1.64) and 0.94 (95% 
CI 0.69 to 1.30), for light, moderate and heavy smoking, 
respectively.
Conclusions Smoking yields similar risks of lung cancer 
in women compared with men. However, these data 
may underestimate the true risks of lung cancer among 
women, as the smoking epidemic has not yet reached 
full maturity in women. Continued efforts to measure the 
sex-specific association of smoking and lung cancer are 
required.
IntrODuCtIOn 
Lung cancer is the leading cause of cancer 
death worldwide with 1.7 million global 
deaths attributed to cigarette smoking in 
2015.1 Tobacco use is the leading cause of 
lung cancer; 55% of lung cancer deaths in 
women and over 70% of lung cancer deaths 
in men are due to smoking.1 These global 
estimates, however, mask major differences 
in smoking prevalence in men and women 
across populations, with rates below 5% for 
women in most Asian and African countries to 
40% and above for men in many parts of Asia 
and Eastern Europe.2 In addition, smoking 
behaviour varies significantly by sex. For 
example, compared with women, men smoke 
more cigars and pipes,3 take puffs of longer 
duration and leave shorter butts,4 which 
each could potentially predispose them to 
greater risks of smoking-related lung cancer. 
Substantial physiological differences between 
the sexes may also result in sex differences 
in the effects of smoking, particularly for 
women. For example, compared with men, 
women have a smaller lung size and different 
airway behaviour,5 which may increase their 
susceptibility to lung cancer at lower levels of 
smoking. A recent meta-analysis showed that 
cigarette smoking confers a greater coronary 
hazard in women compared with men, which 
suggests the possibility that this may also be 
true for the risk of smoking-related lung 
cancer.6 
A study of 50-year trends in smoking-related 
mortality in the USA found that the relative 
risks of smoking-related lung cancer mortality 
were higher in men than women.7 However, 
this sex difference was only apparent in the 
oldest cohorts with the longest follow-up, 
possibly reflecting greater cumulative tobacco 
strengths and limitations of this study
 ► Evidence on the sex-specific association of smoking 
and lung cancer was meta-analysed in over 7 mil-
lion participants across 99 cohort studies.
 ► Several subgroup analyses were performed to ex-
amine the robustness of findings across different 
population subgroups.
 ► However, the smoking epidemic is not yet fully ma-
ture in women and risks of lung cancer in women 
may still be underestimated.
 ► Detailed data on smoking behaviour and data on 
specific subtypes of lung cancer were not available.
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exposure in men than in women. In contrast, a recent 
study in Korea, a population where smoking patterns 
continue to differ between the sexes, suggested that sex 
differences in the impact of smoking on lung cancer risk 
exist and differ by histological subtype.8 Analyses of a 
large UK primary care database showed that moderate 
and heavy smoking more strongly increase the risks of 
lung cancer in women than in men.9
Two recent meta-analyses examined the sex-specific 
association between smoking and lung cancer. In the most 
recent of these, men were found to have a greater risk 
of lung cancer associated with smoking compared with 
women.10 However, virtually all data were from historical 
case–control studies, which have several limitations, and 
the three included prospective studies provided contra-
dictory results. While a previous meta-analysis by Lee et 
al11 included 287 cohort and case–control studies and 
provided sex-specific estimates, single-sex cohorts were 
also included, sex differences in the smoking-related risk 
of lung cancer were not formally compared within studies, 
and only studies published up to 1999 were included.
To resolve this uncertainty, we performed a system-
atic review and meta-analysis of prospective cohort 
studies published to date on the sex-specific associa-
tion of smoking with the risk of fatal and non-fatal lung 
cancer. Our systematic review builds on these previous 
meta-analyses by adding literature from 1999 onwards 
and restricting the analyses to cohort studies, which are 
less prone to bias than case–control studies. In addition, 
we perform several predefined subgroup analyses which 
have not been performed in meta-analyses of cohort 
studies included in previous reviews and supplement 
our findings with results from three sources of indi-
vidual participant data (IPD), not published previously. 
An important a priori consideration is the substantial 
sex difference in the maturity of the smoking epidemic 
with men being at a more advanced stage than women 
in most parts of the world.2 This would be expected to 
translate into lower relative risk (RR) estimates for lung 
cancer in women than in men. Hence, the null hypoth-
esis that smoking confers the same lung cancer hazard 
in both women and men, would be met if the ratio of the 
RRs (RRRs) for lung cancer (women:men) was less than 
unity (reflecting a greater hazard in men than women). 
However, if the RRRs were found to be unity (or higher) 
then this would suggest a greater hazard associated with 
tobacco exposure in women than in men.
MEthODs
search strategy
This review was conducted using a predefined protocol 
and in accordance to the Meta-analysis Of Observational 
Studies in Epidemiology guidelines (online supplemen-
tary eappendix 1). We systematically searched PubMed 
and EMBASE for studies published between 1 January 
1999 and 15 April 2016 that reported on the relationship 
between smoking and lung cancer in men and women 
from a general population. The computer-based searches 
combined medical subject headings and free-text terms 
related to ‘tobacco/smoking’, ‘cancer’, ‘sex’ and ‘cohort 
studies’. The full search criteria are available in online 
supplementary eappendix 2. Articles published before 
1 January 1999 were retrieved from a previous system-
atic review.11 The reference lists of all relevant original 
research and review articles were scanned to capture 
missed studies. Two authors (LMOK and GT) inde-
pendently conducted the screening of studies and any 
disagreement was mediated by a third author (SAEP).
Data extraction
Data were extracted, in duplicate, from studies deemed 
to meet the eligibility criteria. These included details on 
general study characteristics (study name, duration of 
follow-up, year of publication), information about the 
studied population (prevalence of smoking, mean age, 
number of men and women, incidence of lung cancer, 
whether lung cancer was fatal or non-fatal and level of 
adjustment for covariates). We extracted sex-specific 
adjusted measures of RR and 95% confidence intervals 
(CIs).
study selection
Observational cohort studies were included if they 
reported sex-specific RRs or equivalent, on the relation-
ship between smoking and lung cancer. Studies were 
excluded if the variability around the point estimate 
was not reported, if they had not been adjusted for at 
least age, or if the study was performed in a population 
selected on the basis of prior lung cancer or another 
major underlying chronic disease. In the case of duplicate 
reports from the same study, the report with the longest 
follow-up or the highest number of cases was included. 
IPD from studies available to the authors were also used; 
the Asia Pacific Cohort Studies Collaboration (APCSC), 
the National Health and Nutrition Examination Survey III 
(NHANES III) and the Scottish Heart Health Extended 
Cohort Study (SHHEC). The Newcastle-Ottawa Scale 
assessment (NOS) was used to assess the methodological 
quality of all included studies, on a 9-point scale (online 
supplementary eappendix 3 and etable 1).12
Meta-analysis
The primary analysis was a comparison of the sex-specific 
RR of lung cancer (fatal or non-fatal) in current smokers 
versus non-smokers (defined either as former or never 
smokers). For each study, we obtained the natural log of 
the sex-specific RRs and calculated the differences. The 
differences were pooled across studies using random-ef-
fects meta-analysis which allows the RR of lung cancer 
to vary from study to study, weighted by the inverse of 
the variances of the log RRs and then back-transformed 
to obtain the pooled women-to-men RRRs. The SE of 
the log RRR was calculated as the square root of the 
sum of the variance of the two sex-specific log RRs for 
each study. Pooled RRRs were computed separately for 
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studies with only age-adjusted estimates and then for 
those studies with multiple-adjusted estimates. The set 
of multiple adjustments made was allowed to vary by 
study, but had to include at least one other risk factor in 
addition to age. The I² statistic was used to estimate the 
percentage of variability across studies due to between-
study heterogeneity. The presence of publication bias was 
graphically examined using contour funnel plots, plot-
ting the natural log of the RRR against its SE and tested 
using Begg’s test. Predefined subgroup analyses were 
conducted to obtain the adjusted RRRs by study region 
(Asia or non-Asia and Asia, Europe, USA, and Australia 
and New Zealand (ANZ)), year of study baseline (pre-
1985 or post-1985), study endpoint (fatal only or fatal and 
non-fatal combined), number of cigarettes smoked per 
day (>0 to 10, 10–20, >20), study quality ≤6 vs >6 points) 
and follow-up time (≤10 vs >10 years). Random-effects 
meta-analyses were used for all subgroup analyses and 
differences between subgroups were examined using 
meta-regression. To include the largest number of studies 
available, we combined the age-adjusted and multiple-ad-
justed estimates, taking the maximum adjustment set 
available. In secondary analyses, we obtained the sex-spe-
cific RRs and RRRs comparing former smokers to never 
smokers and performed the same set of subgroup anal-
yses. All analyses were performed using Stata V.12.0.
Patient and public involvement
There were no patients or applicable public involved in 
this review.
rEsults
Of the 9519 unique records that were identified through 
the systematic search, 227 qualified for full-text evalua-
tion (figure 1). Of these, 25 separate studies provided 
information about sex differences in the association 
between smoking and lung cancer. This database was 
extended with IPD from APCSC (separately for Asia and 
ANZ), NHANES III and SHHEC leading to a total of 29 
Figure 1 Flow chart of study selection. IPD, individual participant data.
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individual estimates, representing a total of 99 cohort 
studies available for meta-analysis.
The characteristics of the included studies are described 
in table 1. Overall, data were available from 99 cohorts, 
including 7 113 303 individuals (46% women)—not 
accounting for two cohorts that used Census data—and at 
least 51 161 incident cases of lung cancer (31% women). 
Forty-six cohorts were from Asia (61% of the individuals), 
6 were from the USA (28%), 37 were from Europe (10%) 
and 10 were from ANZ (1%). Of 29 studies, 4 studies had 
a quality score of 5 out of 9, 9 studies had a score of 6, 
12 studies had a score of 7 and 4 studies with a score of 8 
(online supplementary etable 1).
Eighteen studies reported on the prevalence of 
smoking, which varied widely by study, region and sex. 
The prevalence of smoking ranged from 1% to 47% 
in women and from 1% to 70% in men. In all but two 
studies, the prevalence of smoking was higher in men 
than women, especially in Asia where typically less than 
10% of women were smokers compared with over 50% 
of men. Smoking cessation rates were also higher among 
men (7%–61%) than women (<1%–39%).
risk of lung cancer in current smokers versus non-smokers
Compared with non-smoking, current smoking was associ-
ated with an age-adjusted RR of lung cancer of 7.48 (95% 
CI 5.29 to 10.60) in women and 8.78 (95% CI 6.13 to 
12.57) in men (table 2 and online supplementary efigure 
1). The pooled age-adjusted women-to-men RRR was 0.81 
(95% CI 0.62 to 1.04), with substantial between-study 
heterogeneity (I2=86%; p<0.001) (table 2 and online 
supplementary efigure 2). The multiple-adjusted RR of 
lung cancer associated with current smoking was 6.99 
(95% CI 5.09 to 9.59) in women and 7.33 (95% CI 4.90 to 
10.96) in men (table 2 and figure 2). The corresponding 
RRR was 0.92 (95% CI 0.72 to 1.16) and between-study 
heterogeneity was substantial (I2=89%; p<0.001) (table 2 
and figure 3). There was no evidence of publication bias 
based on the Begg’s test (p=0.75) (online supplementary 
efigure 3).
The sex difference in the risk of smoking-related lung 
cancer in our main analysis did not differ in subgroup 
analyses stratified by the women-to-men ratio of current 
smokers (p=0.90), women-to-men ratio of lung cancer 
incidence in the studies (p=0.64), year of study base-
line (p=0.66), study endpoint (p=0.21) or study region 
(p=0.73) (table 3). The sex difference in the risk of smok-
ing-related lung cancer in our main analysis also did not 
differ by follow-up time (p=0.83) or study quality (p=0.69). 
The RRR was 0.93 (95% CI 0.72 to 1.20) for studies from 
Asia and 0.87 (95% CI 0.66 to 1.14) for studies from USA, 
Europe or ANZ.
The risk of smoking-related lung cancer increased 
according to the number of cigarettes smoked per day 
in both sexes (table 2). In women, the RRs were 5.30 
(95% CI 3.52 to 7.97), 10.67 (95% CI 7.43 to 15.33) and 
17.09 (95% CI 12.11 to 24.11) across subgroups of <10, 
10 to 20 and >20 cigarettes per day versus non-smoking, 
respectively. Corresponding RRs in men were 4.97 
(95% CI 2.74 to 9.03), 8.93 (95% CI 4.90 to 16.28) and 
14.61 (95% CI 8.33 to 25.59), respectively. The RRRs in 
these subgroups were 0.99 (95% CI 0.65 to 1.52), 1.11 
(95% CI 0.75 to 1.64) and 0.94 (95% CI 0.69 to 1.30), 
respectively.
risk of lung cancer in former smokers versus never smokers
Data from 89 cohorts, including 6 006 725 individuals 
and 38 244 cases of lung cancer, reported on the risk 
of lung cancer in former smokers compared with never 
smokers. The age-adjusted RR of lung cancer associated 
with former smoking was 2.82 (95% CI 2.25 to 3.54) in 
women and 3.01 (95% CI 2.23 to 4.08) in men (table 2 
and online supplementary efigure 4); the age-adjusted 
RRR was 0.88 (95% CI 0.69 to 1.14) (I2=64%; p<0.001) 
(table 2 and online supplementary efigure 5). The corre-
sponding multiple-adjusted RRs were 3.14 (95% CI 2.45 to 
4.03) in women and 3.13 (95% CI 2.06 to 4.76) in men 
(table 2 and online supplementary efigure 6). There was 
no statistical evidence that the effects of smoking cessa-
tion on risk of lung cancer differed between the sexes; 
the multiple-adjusted RRR was 0.89 (95% CI 0.69 to 1.13) 
(I2=69%; p<0.001) (table 2 and online supplementary 
efigure 7). There was no evidence that the RRR differed 
across various subgroup analyses (table 3).
DIsCussIOn
In this systematic review and meta-analysis, comprising 
data from more than 7 million participants, 99 cohort 
studies and over 50 000 incident cases of lung cancer, 
there was no evidence for a difference in the risk of smok-
ing-related lung cancer in women compared with men. 
This was true across a range of subgroup and sensitivity 
analyses. However, as smoking prevalence and inten-
sity were higher in men compared with women in most 
studies included in this analysis, there may yet be an unre-
alised sex difference in the risk of smoking-related lung 
cancer that will only become fully manifest as the smoking 
epidemic reaches full maturity in women.2
The sevenfold higher RRs of lung cancer associated 
with smoking found in the present meta-analysis are 
considerably smaller than the 20-fold increased risks 
reported in the Million Women’s Study 13 and the British 
Doctors Study.14 Both of these studies had the advantage 
of capturing smoking-related risks in populations that 
had smoked for long enough for the effects to become 
fully manifest, highlighting the importance of taking 
into consideration the stage of the tobacco epidemic in 
each sex. The lack of any appreciable sex difference in 
the RRs of lung cancer is surprising given men’s greater 
cumulative exposure to smoking, in most populations, 
compared with women. In addition, men have a greater 
exposure to other risk factors for lung cancer including 
occupational carcinogens.15 Men also smoke more cigars 
and pipes,3 take longer puffs of longer duration and leave 
shorter butts compared with women.4 Hence, it may be 
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reasonable to surmise that the RR estimates of smok-
ing-related lung cancer in women may eventually exceed 
those of men, once cumulative exposure to smoking 
in women is comparable to that in men. In a previous 
meta-analysis, using similar methodology, we found that 
smoking conferred a 25% greater RR of coronary heart 
disease (CHD) in women than in men. Two possible 
explanations for why a similar pattern is not observed for 
lung cancer are that, first, the lag-time between smoking 
and CHD is considerably shorter than for lung cancer,16 
and second the pathways by which smoking increases risk 
are different between CHD and lung cancer.
Although not assessed in this analysis, evidence suggests 
that there are sex differences in the pattern of lung 
cancer among never smokers, with a higher prevalence 
of lung cancer among never-smoking women than never-
smoking men.17 18 A US study among 500000 people 
found a 30% higher incidence of lung cancer in women 
never smokers compared with men never smokers.19 An 
Australian study found the proportion of patients with 
lung cancer who had never smoked was approximately 
18% in women and 3% of men.20 The reasons for this sex 
difference are not clear, but women may have increased 
exposure to environmental tobacco smoke21 or other 
environmental carcinogens such as indoor air pollution22 
or sex-related differences in the metabolism of environ-
mental carcinogens. The possibility of greater exposure to 
environmental tobacco smoke and other environmental 
carcinogens in women compared with men could have 
resulted in a greater underestimation of the association 
between smoking and lung cancer in women than men. 
This, in turn, could have impacted the sex difference in 
risk of smoking-related lung cancer reported in this study.
Our study has several strengths including restriction 
to cohort studies which provide more robust evidence 
of the associations compared with case–control studies. 
Differences between case–control and cohort studies may 
also explain why a previous meta-analysis of case–control 
studies (which included only three cohort studies) 
showed a higher RR of lung cancer in men compared 
with women.10 Other strengths to our study include an 
update of findings to include studies published after 
1999,11 with supplementation of published literature 
with IPD from three established population databases. 
We have also performed a range of prespecified sensi-
tivity analyses and several subgroup analyses which were 
not performed in previous meta-analyses. Our results 
were consistent across regions and irrespective of the 
women-to-men smoking ratio, suggesting that underes-
timation of the association of smoking and lung cancer 
in women due to sex differences in smoking prevalence 
and under-reporting of smoking is unlikely. This is espe-
cially relevant for parts of Asia where the prevalence of 
smoking in women is typically <10% and where smoking 
among women remains relatively socially unacceptable. 
As the up-take of smoking continues among women in 
countries where significant sex differences in smoking 
prevalence exist, the sex-specific risks of lung cancer due 
to smoking may become further apparent. This is also 
true for Western countries where differences in preva-
lence between women and men have reduced substan-
tially over time, with prevalence of smoking in younger 
cohorts of women and men approaching unity.23 The 
limitations of this study include heterogeneity across 
studies in study design, study population, verification 
of smoking status and outcome ascertainment. Assess-
ment of smoking status differed across studies and was 
generally self-reported, which may have introduced 
measurement error.24 Notably, compared with men, 
women are more likely to under-report smoking status, 
Table 2 Sex-specific pooled relative risks (RR) and ratio of relative risks (RRR) for lung cancer associated with smoking
RR in women RR in men RRR
Age adjusted 
  Former versus never 2.82 (2.25 to 3.54) 3.01 (2.23 to 4.08) 0.88 (0.69 to 1.14)
  Current versus not 7.48 (5.29 to 10.60) 8.78 (6.13 to 12.57) 0.81 (0.62 to 1.04)
Multiple adjusted 
  Former versus never 3.14 (2.45 to 4.03) 3.13 (2.06 to 4.76) 0.89 (0.69 to 1.13)
  Current versus not 6.99 (5.09 to 9.59) 7.33 (4.90 to 10.96) 0.92 (0.72 to 1.16)
Maximum adjusted 
  Former versus never 2.92 (2.35 to 3.63) 3.08 (2.31 to 4.11) 0.86 (0.71 to 1.05)
  Current versus not 7.32 (5.58 to 9.61) 8.05 (5.90 to 10.98) 0.89 (0.73 to 1.08)
Cigarettes per day among current smokers versus never (maximum available adjusted)
  10 or less 5.30 (3.52 to 7.97) 4.97 (2.74 to 9.03) 0.99 (0.65 to 1.52)
  10 to 19 10.67 (7.43 to 15.33) 8.93 (4.90 to 16.28) 1.11 (0.75 to 1.64)
  20 or more 17.09 (12.11 to 24.11) 14.61 (8.33 to 25.59) 0.94 (0.69 to 1.30)
Multiple adjusted includes anything that adjusted for more than just age. Maximum available adjustment refers to the most adjustments 
provided in the study. For some studies, this would have been age adjusted whereas other studies adjusted for more factors than age only (ie, 
multiple adjusted). These covariates are listed in table 1.
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and under-reporting is especially prevalent in countries 
where smoking among women is not culturally accept-
able.25 The lack of standardisation across studies in how 
smoking status was obtained, including how smoking dose 
and duration were measured is also a major limitation. In 
addition, there was insufficient data available to examine 
whether there were sex differences in the impact of age 
at smoking initiation and smoking duration on the risk of 
lung cancer. The reference group of non-smokers in our 
analysis of current smoking was composed of former and 
never smokers which may inflate the risks of smoking-re-
lated lung cancer risk among non-smokers. However, we 
have also examined former smoking compared with never 
smoking and demonstrated no appreciable sex differ-
ences in the risks of smoking-related lung cancer in this 
group, which provides some evidence that the inclusion 
of former smokers in the reference category is unlikely to 
have biased the sex difference in our main analysis. We 
quantified sex differences in the risk of lung cancer asso-
ciated with smoking based on RRs rather than absolute 
risks. This might introduce a statistical artefact, in which 
the generally higher absolute risk for lung cancer in men, 
and the same risk difference subsequent to smoking in 
each sex, would translate to a greater RR in women than 
men. However, our previous meta-analyses on risk factors 
for cardiovascular diseases demonstrated that sex differ-
ences in RRs are not inevitable,26 despite differences in 
absolute risks. Compared with absolute risks, RRs are more 
stable across populations with different background risks, 
which makes them suitable for meta-analyses. In addition, 
Figure 2 Multiple-adjusted relative risk (RR) for incident lung cancer in women and men, comparing current smokers to non-
smokers. Multiple-adjusted includes anything that adjusted for more than just age. These covariates are listed in table 1. Figures 
may contain less than 29 studies because we report age-adjusted and multiple-adjusted results separately. Some studies 
only contributed age-adjusted results whereas others only provided multiple-adjusted results. However, the count of unique 
studies that contributed to at least one of these analyses is 29. APCSC, Asia Pacific Cohort Studies Collaboration; ARIC, 
Atherosclerosis Risk in Communities study; CPS, Cancer Prevention Study; EHS, Elderly Health Services; EPIC, European 
Prospective Investigation into Cancer; JACC, Japan Collaborative Cohort Study; JPHC, Japan Public Health Centre Study; 
NHANES III, National Health And Nutrition Examination Survey III; NHIS, National Health Interview Survey; NIH-AARP, National 
Institutes of Health American Association of Retrired Persons Diet and Health Study; SHHEC, Scottish Heart Health Extended 
Cohort Study; TPCS, Three-Prefecture Cohort Study.  on
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RRs are reported much more commonly than absolute 
risks. In our review, no studies reported adjusted absolute 
risks, with standard errors, that allow for meta-analyses. 
We, therefore, believe that use of RRs in the present anal-
ysis is appropriate. In addition, while we have aimed to 
assess study quality using the widely accepted and used 
NOS, the value and contribution of quality assessment 
scales such as this to systematic reviews and meta-analyses 
continues to be debated.27–29 Finally, there are differences 
between men and women in histological subtypes of lung 
cancer. Adenocarcinoma is more common in women 
and squamous cell carcinoma is more common in men.30 
Smoking is more strongly associated with squamous cell 
carcinoma than adenocarcinoma.30 Few studies reported 
the sex-specific association of smoking with histological 
subtypes of cancer, which precluded the examination of 
sex differences in the association of smoking-related lung 
cancer subtypes and this remains an important limitation 
of our review.30 Further studies of the smoking-related 
risks of lung cancer in women and men are required as 
the smoking epidemic reaches its full maturity in women. 
Given the later up-take of smoking in women, studies 
which allow sufficient lag time for lung cancer to develop 
are essential. In addition, reducing under-reporting 
of smoking in women, using standardised and robust 
methods for the ascertainment of smoking status and 
smoking behaviours and more extensive measurement 
and adjustment for confounders which differ by sex (such 
as exposure to environmental tobacco smoke) is also 
important for future work, as well as examination of histo-
logical subtypes of lung cancer which was not possible in 
this review.
In conclusion, this meta-analysis, summarising all avail-
able literature to date, shows that the effect of smoking on 
risk of lung cancer is similar in women and men. However, 
these data may yet underestimate the true RR of smok-
ing-related lung cancer in women, given later uptake and 
lower intensity of smoking in women. Although strides 
have been made in reducing smoking rates particularly in 
high-income countries, continuing efforts to measure the 
effects of smoking on disease outcomes are required, as 
the smoking epidemic has not yet reached its global peak, 
particularly among women. In addition, tobacco control 
Figure 3 Multiple-adjusted women-to-men ratio of relative risks (RRR) for incident lung cancer, comparing current smokers 
to non-smokers. Multiple-adjusted includes anything that adjusted for more than just age. These covariates are listed in 
table 1. Figures may contain less than 29 studies because we report age-adjusted and multiple-adjusted results separately. 
Some studies only contributed age-adjusted results whereas others only provided multiple-adjusted results. However, the count 
of unique studies that contributed to at least one of these analyses is 29. APCSC, Asia Pacific Cohort Studies Collaboration; 
ARIC, Atherosclerosis Risk in Communities study; CPS, Cancer Prevention Study; EHS, Elderly Health Services; EPIC, 
European Prospective Investigation into Cancer; JACC, Japan Collaborative Cohort Study; JPHC, Japan Public Health Centre 
Study; NHANES III, National Health And Nutrition Examination Survey III; NHIS, National Health Interview Survey; NIH-AARP, 
National Institutes of Health American Association of Retired Persons Diet and Health Study; SHHEC, Scottish Heart Health 
Extended Cohort Study; TPCS, Three-Prefecture Cohort Study. 
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programmes that dissuade both sexes from smoking but 
which also encourage individuals to quit remain a priority.
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Table 3 Maximally adjusted pooled women to men ratio of relative risks (RRR) for lung cancer associated with smoking, in 
subgroup analyses
N 
studies Former versus never
P for 
interaction*
N 
studies Current versus not
P for 
interaction*
Study region
  Asia 40 1.07 (0.83 to 1.37) 46 0.93 (0.72 to 1.20)
  Non-Asia 49 0.73 (0.58 to 0.93) 0.06 53 0.87 (0.66 to 1.14) 0.73
Study region
  Asia 40 1.07 (0.83 to 1.37) 46 0.93 (0.72 to 1.20)
  USA 5 0.60 (0.42 to 0.84) 6 0.58 (0.37 to 0.91)
  Europe 36 0.81 (0.60 to 1.10) 37 0.99 (0.63 to 1.57)
  ANZ 8 1.41 (0.65 to 3.04) 0.55 10 1.11 (0.97 to 1.28) 0.69
Year of study baseline
  1985 or before 23 0.79 (0.56 to 1.12) 25 0.96 (0.66 to 1.40)
  After 1985 66 0.92 (0.73 to 1.16) 0.43 74 0.85 (0.68 to 1.06) 0.66
Women-to-men smoking prevalence
  >67% lower in women 39 1.16 (0.83 to 1.62) 43 0.96 (0.72 to 1.28)
  33%–67% lower in women 19 0.72 (0.51 to 1.03) 20 0.75 (0.50 to 1.14)
  0%–33% lower in women 28 0.78 (0.59 to 1.03) 0.26 29 0.97 (0.59 to 1.58) 0.90
Women-to-men lung cancer rate
  ≥50% lower in women 80 0.85 (0.65 to 1.10) 83 0.85 (0.62 to 1.17)
  0%–50% lower in women 6 0.83 (0.61 to 1.13) 0.79 9 0.94 (0.68 to 1.31) 0.64
Study endpoint
  Fatal lung cancer only 57 0.94 (0.68 to 1.29) 67 0.97 (0.77 to 1.21)
  Fatal and non-fatal lung cancer 32 0.80 (0.64 to 1.01) 0.57 32 0.72 (0.48 to 1.06) 0.21
Duration of follow-up
  ≤10 years 48 0.90 (0.60 to 1.35) 53 0.91 (0.68 to 1.24)
  >10 years 41 0.85 (0.71 to 1.05) 0.92 46 0.87 (0.67 to 1.12) 0.83
Study quality
  ≤6 points 58 0.85 (0.64 to 1.13) 61 0.84 (0.53 to 1.12)
  >6 points 31 0.89 (0.66 to 1.20) 0.81 38 0.93 (0.72 to 1.20) 0.69
Random-effects meta-analyses were used for all subgroup analyses and differences between subgroups were examined using meta-
regression.
*P for interaction assessed using meta-regression.
ANZ, Australia and New Zealand.
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